Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Revised Communication Strategy

<< Previous

Bullboard Posts

Next >>

Comment by davikingon Feb 16, 2024 3:43pm

172 Views

Post# 35884933

RE:RE:RE:Revised Communication Strategy

MMAB,
If, " there are no serious discussions with Baxter in the next two months regarding Baxter buying Spectral", this stock is toast!
They will have seen the results of the trial and if those don't follow what has been touted by Kellum, Seto, et al, and doesn't interest them, who else will be?
Since Kellum is on vacation for the last month, that is a bit concerning!

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1